Evotec SE
XETRA:EVT
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Realty Income Corp
NYSE:O
|
Real Estate
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Evotec SE
Other Receivables
Evotec SE
Other Receivables Peer Comparison
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/xetra/gxi.png)
Competitive Other Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Other Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
E
|
Evotec SE
XETRA:EVT
|
Other Receivables
€67.3m
|
CAGR 3-Years
55%
|
CAGR 5-Years
30%
|
CAGR 10-Years
67%
|
![]() |
Gerresheimer AG
XETRA:GXI
|
Other Receivables
€85.9m
|
CAGR 3-Years
30%
|
CAGR 5-Years
23%
|
CAGR 10-Years
11%
|
S
|
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
|
Other Receivables
€61.3m
|
CAGR 3-Years
39%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Evotec SE's Other Receivables?
Other Receivables
67.3m
EUR
Based on the financial report for Mar 31, 2024, Evotec SE's Other Receivables amounts to 67.3m EUR.
What is Evotec SE's Other Receivables growth rate?
Other Receivables CAGR 10Y
67%
Over the last year, the Other Receivables growth was 17%. The average annual Other Receivables growth rates for Evotec SE have been 55% over the past three years , 30% over the past five years , and 67% over the past ten years .